U.S. Markets open in 6 hrs 20 mins

BioCryst Pharma wins federal contract to continue making Ebola drug

March 31 (Reuters) - BioCryst Pharmaceuticals Inc said it won a U.S. government contract for the continued development of its potential treatment for viral diseases, including Ebola.

The 18-month contract includes a base value of $12.1 million to support manufacturing, as well as $22.9 million in additional development options that can be exercised by the government.

(Reporting By Samantha Kareen Nair; Editing by Savio D'Souza)